| 2024-04 |
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease |
European Journal of Gastroenterology and Hepatology
|
| 2024-03 |
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease |
Gut
|
| 2024-03 |
Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study |
Metabolism: Clinical and Experimental
|
| 2024-01 |
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B |
Journal of Hepatology
|
| 2023-12 |
Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy |
Journal of the Formosan Medical Association = Taiwan yi zhi
|
| 2023-11 |
Association of Alcohol Consumption With Liver Cancer and All-Cause Mortality in Chronic Hepatitis B Patients Without Cirrhosis |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2023-11 |
Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma |
Cell Communication and Signaling
|
| 2023-11 |
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis |
Alimentary Pharmacology and Therapeutics
|
| 2023-09 |
Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients |
International Journal of Cancer
|
| 2023-09 |
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study |
Journal of Gastroenterology and Hepatology
|
| 2023-08 |
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis |
Journal of Gastroenterology and Hepatology
|
| 2023-08 |
How can we improve surveillance system for alcohol-associated hepatocellular carcinoma? |
Journal of Gastroenterology and Hepatology (Australia)
|
| 2023-08 |
Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2023-08 |
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B |
Liver international : official journal of the International Association for the Study of the Liver
|
| 2023-08 |
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis |
Clinical Gastroenterology and Hepatology
|
| 2023-07 |
Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study |
The Korean Journal of Internal Medicine
|
| 2023-06 |
Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study |
American Journal of Gastroenterology
|
| 2023-05 |
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease |
Gut and Liver
|
| 2023-05 |
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study |
JHEP Reports
|
| 2023-04 |
Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy |
Alimentary Pharmacology and Therapeutics
|
| 2023-04 |
Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma |
European Journal of Clinical Investigation
|
| 2023-03 |
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease |
Liver International
|
| 2023-02 |
CAGE-B and SAGE-B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE-B |
Journal of Digestive Diseases
|
| 2023-02 |
Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis |
Hepatology Communications
|
| 2023-02 |
Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma |
European Journal of Gastroenterology and Hepatology
|
| 2023-01 |
The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA |
Journal of Gastroenterology and Hepatology
|
| 2023-01 |
Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study |
European Journal of Internal Medicine
|
| 2023-01 |
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis |
DIAGNOSTICS
|
| 2023-01 |
Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma |
Frontiers in Endocrinology
|
| 2023-01 |
Self-Management and Associated Factors among Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study |
International Journal of Environmental Research and Public Health
|
| 2022-12 |
New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease |
Clinical and Translational Gastroenterology
|
| 2022-12 |
Liver Diseases in South Korea: A Pulse Check of the Public’s Knowledge, Awareness, and Behaviors |
Yonsei Medical Journal
|
| 2022-12 |
Effect of metabolic dysfunction-associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study |
Hepatology Research
|
| 2022-11 |
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B |
Liver International
|
| 2022-10 |
Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study |
CANCERS
|
| 2022-10 |
MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups |
DIGESTIVE DISEASES AND SCIENCES
|
| 2022-09 |
Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study |
Diabetes and Metabolism
|
| 2022-09 |
Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study |
Hepatology Communications
|
| 2022-08 |
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model |
Gastroenterology Report
|
| 2022-07 |
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study |
DIABETES & METABOLISM
|
| 2022-07 |
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B |
Digestive Diseases and Sciences
|
| 2022-07 |
Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
| 2022-05 |
Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone |
Clinical Pharmacology in Drug Development
|
| 2022-05 |
Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B |
LIVER INTERNATIONAL
|
| 2022-05 |
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels |
JOURNAL OF HEPATOLOGY
|
| 2022-05 |
Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2022-04 |
Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria |
Frontiers in Medicine
|
| 2022-04 |
Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-04 |
Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL |
HEPATOLOGY INTERNATIONAL
|
| 2022-04 |
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE) |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-04 |
Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-03 |
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease |
Gut and Liver
|
| 2022-03 |
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease |
GUT AND LIVER
|
| 2022-03 |
Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease |
DIABETOLOGIA
|
| 2022-02 |
Predictors of Sarcopenia in an Obese Asian Population |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
|
| 2022-02 |
Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases: A large-scale Asian study |
JOURNAL OF VIRAL HEPATITIS
|
| 2022-02 |
Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-02 |
A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor- β signaling |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2022-02 |
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study |
Cancers
|
| 2022-02 |
Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis |
Diagnostics
|
| 2022-02 |
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA ,2,000 IU/mL |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2022-01 |
Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
| 2022-01 |
Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-01 |
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients |
Cancers
|
| 2022-01 |
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization |
Cancers
|
| 2021-12 |
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients |
HEPATOLOGY INTERNATIONAL
|
| 2021-12 |
Novel liver stiffness-based nomogram for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection initiating antiviral therapy |
Cancers
|
| 2021-11 |
No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-11 |
YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation |
HEPATOLOGY
|
| 2021-10 |
Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2021-10 |
Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease |
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
|
| 2021-10 |
Development and Pilot Testing of a Smartphone-Based Self-Care Program for Patients with Chronic Hepatitis B |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
|
| 2021-10 |
Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-10 |
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-10 |
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B |
HEPATOLOGY INTERNATIONAL
|
| 2021-10 |
Development and initial validation of the nonalcoholic fatty liver disease self-management questionnaire |
RESEARCH IN NURSING & HEALTH
|
| 2021-09 |
Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-09 |
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease |
Cancers
|
| 2021-09 |
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-08 |
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy |
HEPATOLOGY INTERNATIONAL
|
| 2021-07 |
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus & ndash;related hepatocellular carcinoma |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-07 |
Pharmacokinetics and safety of evogliptin in hepatically impaired patients |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
|
| 2021-07 |
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study |
DIGESTIVE DISEASES AND SCIENCES
|
| 2021-07 |
Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease |
LIVER INTERNATIONAL
|
| 2021-06 |
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models |
CELL DEATH & DISEASE
|
| 2021-06 |
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|